Cited by 125Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice

Open access

Wirths, Oliver, Multhaup, Gerd, Czech, Christian, Feldmann, Nicole, Blanchard, Véronique, Tremp, Günter, Beyreuther, Konrad, Pradier, Laurent, Bayer, Thomas A.·2002·Brain Pathology

DOI 10.1111/j.1750-3639.2002.tb00442.xPMC PMC8095864

Open this paper in CoChat — free account

Abstract

Neuropil deposition of beta-amyloid peptides A beta40 and A beta42 is believed to be the key event in the neurodegenerative processes of Alzheimer's disease (AD). Since A beta seems to carry a transport signal that is required for axonal sorting of its precursor beta-amyloid precursor protein (APP), we studied the intraneuronal staining profile of A beta peptides in a transgenic mouse model expressing human mutant APP751 (KM670/671NL and V7171) and human mutant presenilin-1 (PS-1 M146L) in neurons. Using surface plasmon resonance we analyzed the A beta antibodies and defined their binding profile to APP, A beta40 and A beta42. Immunohistochemical staining revealed that intraneuronal A beta40 and A beta42 staining preceded plaque deposition, which started at 3 months of age. A beta was observed in the somatodendritic and axonal compartments of many neurons. Interestingly, the striatum, which lacks transgenic APP expression harbored many plaques at 10 months of age. This is most likely due to an APP/A beta transport problem and may be a model region to study APP/A beta trafficking as an early pathological event.

Integrity signals

Registry

Crossref · 10.1111/j.1750-3639.2002.tb00442.x

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Self-citation
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citation
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921

Show all 64 references

Sorted by citations

Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.027 · Cited by 623
“Axonal swellings have been previously reported in other APP transgenic mouse models to a variable extent (Stokin et al., 2005; Wirths et al., 2006; Wirths et al., 2007) and are also present in Tau (Probst et al., 2000; Spittaels et al., 1999) or ApoE-based (Tesseur et al., 2000) AD transgenic mouse…”
BackgroundSelf-citation
Survey of the year 2003 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.726 · Cited by 506
Massive CA1/2 Neuronal Loss with Intraneuronal and N-Terminal Truncated Aβ42 Accumulation in a Novel Alzheimer Transgenic Model
Casas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400
Self-citation
A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade
Wirths, O., Multhaup, G., & Bayer, T. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02737.x · Cited by 357
Self-citation
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease
Gouras, G. K., Almeida, C. G., & Takahashi, R. H. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.022 · Cited by 338
Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis
Keil, U., Bonert, A., Marques, C. A., Scherping, I., Weyermann, J., Strosznajder, J. B., Müller-Spahn, F., Haass, C., Czech, C., Pradier, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405600200 · Cited by 287
Self-citation
Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice
Blanchard, V., Moussaoui, S., Czech, C., Touchet, N., Bonici, B., Planche, M., Canton, T., Jedidi, I., Gohin, M., Wirths, O., et al. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00252-8 · Cited by 283
Self-citation
The Arctic Alzheimer mutation facilitates early intraneuronal Aβ aggregation and senile plaque formation in transgenic mice
Lord, A., Kalimo, H., Eckman, C., Zhang, X.-Q., Lannfelt, L., & Nilsson, L. N. G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.12.007 · Cited by 260
Intracellular accumulation of amyloid-beta – a predictor for synaptic dysfunction and neuron loss in Alzheimer’s disease
Bayer (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00008 · Cited by 252
Mechanisms of Aβ mediated neurodegeneration in Alzheimer's disease
Crouch, P. J., Harding, S.-M. E., White, A. R., Camakaris, J., Bush, A. I., & Masters, C. L. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.013 · Cited by 254
Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice
Little, C. S., Hammond, C. J., MacIntyre, A., Balin, B. J., & Appelt, D. M. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00127-1 · Cited by 243
Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline
Reddy, P. H., Mańczak, M., Mao, P., Calkins, M. J., Reddy, A. P., & Shirendeb, U. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100504 · Cited by 247
Co-Localization of Amyloid Beta and Tau Pathology in Alzheimer's Disease Synaptosomes
Fein, J. A., Sokolow, S., Miller, C. A., Vinters, H. V., Yang, F., Cole, G. M., & Gylys, K. H. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070829 · Cited by 218
Membrane Trafficking Pathways in Alzheimer's Disease
Rajendran, L., & Annaert, W. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01332.x · Cited by 171
Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
Wirths, O., Breyhan, H., Cynis, H., Schilling, S., Demuth, H.-U., & Bayer, T. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0557-5 · Cited by 174
Self-citation
Subcellular Topography of Neuronal Aβ Peptide in APPxPS1 Transgenic Mice
Langui, D., Girardot, N., El Hachimi, K. H., Allinquant, B., Blanchard, V., Pradier, L., & Duyckaerts, C. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63405-0 · Cited by 165
Self-citation
Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody
Youmans, K. L., Tai, L. M., Kanekiyo, T., Stine Jr, W. B., Michon, S.-C., Nwabuisi-Heath, E., Manelli, A. M., Fu, Y., Riordan, S., Eimer, W. A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-8 · Cited by 164
Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice
Schüssel, K., Schäfer, S., Bayer, T. A., Czech, C., Pradier, L., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.003 · Cited by 149
Self-citation
Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer’s Disease
Richard, B. C., Kurdakova, A., Baches, S., Bayer, T. A., Weggen, S., & Wirths, O. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-143120 · Cited by 142
Self-citation
Extracellular amyloid formation and associated pathology in neural grafts
Meyer‐Luehmann, M., Stalder, M., Herzig, M. C., Kaeser, S. A., Kohler, E., Pfeifer, M., Boncristiano, S., Mathews, P. M., Mercken, M. H., Abramowski, D., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1022 · Cited by 137
Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease
Wirths, O., Breyhan, H., Marcello, A., Côtel, M.-C., Brück, W., & Bayer, T. A. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.06.011 · Cited by 140
Self-citation
Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila
Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130
Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease
Wirths, O., Weis, J., Szczygielski, J., Multhaup, G., & Bayer, T. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0041-4 · Cited by 130
Self-citation
Mechanisms of Amyloid‐Beta Peptide Uptake by Neurons: The Role of Lipid Rafts and Lipid Raft‐Associated Proteins
Lai, A. Y., & McLaurin, J. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/548380 · Cited by 132
Pathophysiology of Alzheimer's Disease
Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 137
Transient intraneuronal Aβ rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice
Christensen, D. Z., Kraus, S. L., Flohr, A., Cotel, M.-C., Wirths, O., & Bayer, T. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0451-6 · Cited by 126
“different APP/PS1 transgenic mouse model [14, 28].”
MethodSelf-citation
Age-dependent axonal degeneration in an Alzheimer mouse model
Wirths, O., Weis, J., Kayed, R., Saido, T. C., & Bayer, T. A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.07.021 · Cited by 127
Self-citation
Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease
Takahashi, H., Brasnjevic, I., Rutten, B. P. F., Van Der Kolk, N., Perl, D. P., Bouras, C., Steinbusch, H. W. M., Schmitz, C., Hof, P. R., & Dickstein, D. L. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0242-4 · Cited by 124
Single-domain antibodies recognize selectively small oligomeric forms of amyloid β, prevent Aβ-induced neurotoxicity and inhibit fibril formation
Lafaye, P. J., Achour, I., England, P., Duyckaerts, C. J., & Rougeon, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.008 · Cited by 121
Accumulation of intraneuronal Aβ correlates with ApoE4 genotype
Christensen, D. Z., Schneider-Axmann, T., Lucassen, P. J., Bayer, T. A., & Wirths, O. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0666-1 · Cited by 120
Self-citation
Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice
Rutten, B. P. F., van der Kolk, N. M., Schäfer, S., van Zandvoort, M. A. M. J., Bayer, T. A., Steinbusch, H. W. M., & Schmitz, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62963-x · Cited by 117
Self-citation
Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Götz, J., Ittner, L. M., & Kins, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03955.x · Cited by 119
Insights into Alzheimer disease pathogenesis from studies in transgenic animal models
Schaeffer, E. L., Figueiró, M., & Gattaz, W. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300006 · Cited by 114
Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology
Ferretti, M. T., Allard, S., Partridge, V., Ducatenzeiler, A., & Cuello, A. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-62 · Cited by 120
Alzheimer's in 3D culture: Challenges and perspectives
D'Avanzo, C., Aronson, J., Kim, Y. H., Choi, S. H., Tanzi, R. E., & Kim, D. Y. (2015) · BioEssays · doi:10.1002/bies.201500063 · Cited by 111
Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer’s disease cases
Wirths, O., Bethge, T., Marcello, A., Harmeier, A., Jawhar, S., Lucassen, P. J., Multhaup, G., Brody, D. L., Esparza, T., Ingelsson, M., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0314-x · Cited by 106
Self-citation
Intracellular Aβ pathology and early cognitive impairments in a transgenic rat overexpressing human amyloid precursor protein: a multidimensional study
Iulita, M. F., Allard, S. T. M., Richter, L., Munter, L. M., Ducatenzeiler, A., Weise, C., Carmo, S. D., Klein, W. L., Multhaup, G., & Cuello, A. C. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-61 · Cited by 106
Self-citation
Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles
Multhaup, G., Huber, O., Buée, L., & Galas, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.677211 · Cited by 101
Self-citation
A survey of the year 2002 commercial optical biosensor literature
Rich, R. L., & Myszka, D. G. (2003) · Journal of Molecular Recognition · doi:10.1002/jmr.649 · Cited by 93
Mice as models: Transgenic approaches and Alzheimer's disease
Games, D., Buttini, M., Kobayashi, D. T., Schenk, D., & Seubert, P. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s316 · Cited by 93
Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models
Wirths, O., & Bayer, T. A. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.02.001 · Cited by 93
Self-citation
Aβ Internalization by Neurons and Glia
Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 94
Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1
Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G. L., Pradier, L., & Brion, J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.007 · Cited by 90
Self-citation
Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats
Tian, L., Guo, R., Yue, X., Lv, Q., Ye, X., Wang, Z., Chen, Z., Wu, B., Xu, G., & Liu, X. (2012) · Brain Research · doi:10.1016/j.brainres.2011.12.059 · Cited by 84
Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer’s disease
Saul, A., Sprenger, F., Bayer, T. A., & Wirths, O. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.003 · Cited by 88
Self-citation
Intracellular Aβ triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease
Christensen, D. Z., Bayer, T. A., & Wirths, O. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.022 · Cited by 77
Self-citation
Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies
Cuello, A. C. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00101.x · Cited by 80
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
Self-citation
Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease
Barrier, L., Ingrand, S. S., Damjanac, M., Bilan, A. R., Hugon, J., & Page, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.08.002 · Cited by 68
Development of a Platinum Complex as an anti‐Amyloid Agent for the Therapy of Alzheimer’s Disease
Kenche, V. B., Hung, L. W., Perez, K. A., Volitakes, I., Ciccotosto, G., Kwok, J., Critch, N., Sherratt, N., Cortés, M., Lal, V., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209885 · Cited by 68
Age-Related Brain Expression and Regulation of the Chemokine CCL4/MIP-1β in APP/PS1 Double-Transgenic Mice
Zhu, M., Allard, J. S., Zhang, Y., Perez, E., Spangler, E. L., Becker, K. G., & Rapp, P. R. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000060 · Cited by 69
Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in alzheimer’s disease research
Aguilar, M. I., & Small, D. H. (2005) · Neurotoxicity Research · doi:10.1007/bf03033773 · Cited by 54
Synaptophysin depletion and intraneuronal Aβ in organotypic hippocampal slice cultures from huAPP transgenic mice
Durrant, C. S., & Coleman, M. P. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0110-7 · Cited by 55
Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice
Hüttenrauch, M., Walter, S., Kaufmann, M., Weggen, S., & Wirths, O. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0167-x · Cited by 56
Self-citation
Enhanced generation of intracellular Aβ42 amyloid peptide by mutation of presenilins PS1 and PS2
Takeda, K., Araki, W., & Tabira, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03135.x · Cited by 53
Internalisation and toxicity of amyloid‐β 1‐42 are influenced by its conformation and assembly state rather than size
Vadukul, D. M., Maina, M. B., Franklin, H., Nardecchia, A., Serpell, L. C., & Marshall, K. E. (2020) · FEBS Letters · doi:10.1002/1873-3468.13919 · Cited by 51
Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in β‐amyloid load
Santiard-Baron, D., Langui, D., Delehedde, M., Delatour, B., Schombert, B., Touchet, N., Tremp, G. L., Paul, M.-F., Blanchard, V., Sergeant, N., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03026.x · Cited by 51
Self-citation
Review on the APP/PS1KI mouse model: intraneuronal Aβ accumulation triggers axonopathy, neuron loss and working memory impairment
Bayer, T. A., & Wirths, O. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00372.x · Cited by 60
Self-citation
The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease
Huang, C., Chu, H., Ma, Y., Zhou, Z., Dai, C., Huang, X., Fang, L., Ao, Q., & Huang, D. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.08.015 · Cited by 50
Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer’s Disease
Giesers, N. K., & Wirths, O. (2020) · ASN Neuro · doi:10.1177/1759091420925356 · Cited by 47
Self-citation
Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Aβ peptides in mouse models of Alzheimer's disease
Christensen, D. Z., Bayer, T. A., & Wirths, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.014 · Cited by 47
Self-citation
High intracellular concentrations of amyloid‐beta block nuclear translocation of phosphorylated CREB
Arvanitis, D. N., Ducatenzeiler, A., Ou, J.-N., Grodstein, E. I., Andrews, S. D., Tendulkar, S. R., Ribeiro‐da‐Silva, A., Szyf, M., & Cuello, A. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04704.x · Cited by 46
Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models
Reinert, J., Richard, B. C., Klafki, H., Friedrich, B., Bayer, T. A., Wiltfang, J., Kovács, G. G., Ingelsson, M., Lannfelt, L., Paetau, A. E., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0294-7 · Cited by 44
Self-citation
β-Amyloid Inhibits Protein Prenylation and Induces Cholesterol Sequestration by Impairing SREBP-2 Cleavage
Mohamed, A., Saavedra, L., Pardo, A. D., Sipione, S., & Chaves, E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0630-12.2012 · Cited by 44
Neuroprotective effect of emodin against Alzheimer's disease via Nrf2 signaling in U251 cells and APP/PS1 mice
Li, Z., Bi, H. C., Jiang, H., Song, J., Meng, Q., Zhang, Y., & Fei, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11747 · Cited by 40
No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the β-cleaved C-terminal APP fragment
Rutten, B. P. F., Wirths, O., van de Berg, W. D. J., Lichtenthaler, S. F., Vehoff, J., Steinbusch, H. W. M., Korr, H., Beyreuther, K. T., Multhaup, G., Bayer, T. A., et al. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00015-3 · Cited by 39
Self-citation
BACE inhibitor reduces APP-β-C-terminal fragment accumulation in axonal swellings of okadaic acid-induced neurodegeneration
Yoon, S. Y., Choi, J. E., Yoon, J. H., Huh, J., & Kim, D. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.013 · Cited by 38
Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels
Köhler, C., Ebert, U., Baumann, K., & Schröder, H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.009 · Cited by 37
N‐terminal heterogeneity of parenchymal and vascular amyloid‐β deposits in Alzheimer’s disease
Zampar, S., Klafki, H., Sritharen, K., Bayer, T. A., Wiltfang, J., Rostagno, A. A., Ghiso, J. A., Miles, L. A., & Wirths, O. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12637 · Cited by 36
Self-citation
Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer’s disease
Li, W., Pang, Y., Wang, Y., Mei, F., Guo, M., Wei, Y., Li, X., Qin, W., Wang, W., Jia, L., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02930-7 · Cited by 41
Aβ38 in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models
Reinert, J., Martens, H., Hüttenrauch, M., Kolbow, T., Lannfelt, L., Ingelsson, M., Paetau, A. E., Verkkoniemi‐Ahola, A., Bayer, T. A., & Wirths, O. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131373 · Cited by 33
Self-citation
Transverse relaxation time reflects brain amyloidosis in young APP/PS1 transgenic mice
Tayara, N. E. T. E., Volk, A., Dhénain, M., & Delatour, B. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21266 · Cited by 33
Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function
Barucker, C., Bittner, H. J., Chang, P. K. ‐., Cameron, S., Hancock, M. A., Liebsch, F., Hossain, S., Harmeier, A., Shaw, H. S., Charron, F. M., et al. (2015) · Scientific Reports · doi:10.1038/srep15410 · Cited by 32
Self-citation
Intercellular communication in the brain through a dendritic nanotubular network
Chang, M., Krüssel, S., Parajuli, L. K., Kim, J., Lee, D., Merodio, A., Kwon, J., Okabe, S., & Kwon, H. (2025) · Science · doi:10.1126/science.adr7403 · Cited by 32
Intramembrane proteolysis within lysosomes
Schröder, B., & Säftig, P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.012 · Cited by 28
Of mice and men: more neurobiology in dementia
Codita, A., Winblad, B. G., & Mohammed, A. H. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000245757.06374.6a · Cited by 29
Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation
Christensen, D. Z., Hüttenrauch, M., Mitkovski, M., Pradier, L., & Wirths, O. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00139 · Cited by 29
Self-citation
Abundance of Aβ5-xlike immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer’s disease
Guzmán, E. A., Bouter, Y., Richard, B. C., Lannfelt, L., Ingelsson, M., Paetau, A. E., Verkkoniemi‐Ahola, A., Wirths, O., & Bayer, T. A. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-13 · Cited by 27
Self-citation
Potential applications of SPR in early diagnosis and progression of Alzheimer's disease
Liu, L., Xia, N., & Wang, J. (2012) · RSC Advances · doi:10.1039/c2ra00667g · Cited by 27
Development and Technical Validation of an Immunoassay for the Detection of APP669–711 (Aβ−3–40) in Biological Samples
Klafki, H., Rieper, P., Matzen, A., Zampar, S., Wirths, O., Vogelgsang, J. S., Osterloh, D., Rohdenburg, L., Oberstein, T. J., Jahn, O., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186564 · Cited by 24
Self-citation
Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice
Bader, A. S., Gnädig, M.-U., Fricke, M., Büschgens, L., Berger, L. J., Klafki, H., Meyer, T., Jahn, O., Weggen, S., & Wirths, O. (2023) · Life · doi:10.3390/life13041053 · Cited by 26
Self-citation
Intraneuronal β-Amyloid Is a Major Risk Factor – Novel Evidence from the APP/PS1KI Mouse Model
Bayer, T. A., Breyhan, H., Duan, K., Rettig, J., & Wirths, O. (2008) · Neurodegenerative Diseases · doi:10.1159/000113684 · Cited by 24
Self-citation
Endogenous β-amyloid peptide synthesis modulates cAMP response element-regulated gene expression in PC12 cells
Echeverrı́a, V., Ducatenzeiler, A., Chen, C. H., & Cuello, A. C. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.057 · Cited by 24
Oligomeric Pyroglutamate Amyloid-β is Present in Microglia and a Subfraction of Vessels in Patients with Alzheimer's Disease: Implications for Immunotherapy
Wirths, O., Hillmann, A., Pradier, L., Härtig, W., & Bayer, T. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121945 · Cited by 21
Self-citation
Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias
Saul, A., Lashley, T., Révész, T., Holton, J. L., Ghiso, J. A., Coomaraswamy, J., & Wirths, O. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.014 · Cited by 23
Self-citation
Decreased plasma cholesterol levels during aging in transgenic mouse models of Alzheimer's disease
Wirths, O., Thelen, K., Breyhan, H., Luzón-Toro, B., Hoffmann, K.-H., Falkai, P., Lütjohann, D., & Bayer, T. A. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.10.007 · Cited by 20
Self-citation
Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s disease
Marengo, L., Armbrust, F., Schoenherr, C., Storck, S. E., Schmitt, U., Zampar, S., Wirths, O., Altmeppen, H. C., Glatzel, M., Kaether, C., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04205-5 · Cited by 25
Self-citation
Age-dependent loss of dentate gyrus granule cells in APP/PS1KI mice
Côtel, M.-C., Bayer, T. A., & Wirths, O. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.052 · Cited by 19
Self-citation
Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
Zampar, S., & Wirths, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105191 · Cited by 18
Self-citation
Synergistic Effect on Neurodegeneration by N-Truncated Aβ4−42 and Pyroglutamate Aβ3−42 in a Mouse Model of Alzheimer's Disease
López‐Noguerola, J. S., Gießen, N. M.-E., Ueberück, M., Meißner, J. N., Pelgrim, C. E., Adams, J., Wirths, O., Bouter, Y., & Bayer, T. A. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00064 · Cited by 18
Self-citation
Octodon degus: a strong attractor for Alzheimer research.
Castro-Fuentes, R., & Socas-Pérez, R. (2013) · Europe PMC (PubMed Central) · Cited by 16
Plasma homocysteine levels are not increased in murine models of Alzheimer's disease
Santiard-Baron, D., Aupetit, J., & Janel, N. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.09.001 · Cited by 16
N-Terminal Truncated Aβ4-42 Is a Substrate for Neprilysin Degradation in vitro and in vivo
Hornung, K. A., Zampar, S., Engel, N., Klafki, H., Liepold, T., Bayer, T. A., Wiltfang, J., Jahn, O., & Wirths, O. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181134 · Cited by 15
Self-citation
Effect of amyloids on the vesicular machinery: implications for somatic neurotransmission
Das, A. K., Pandit, R., & Maiti, S. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0187 · Cited by 14
Evidence for the accumulation of Abeta immunoreactive material in the human brain and in transgenic animal models
Cuello, A. C., Allard, S., & Ferretti, M. T. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.020 · Cited by 15
Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice
Zhang, H., Zhu, K., Meng, Y., Ding, L., Wang, J.-C., Yin, W., Yan, Y., & Cao, Y. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.07.019 · Cited by 13
Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains
Wirths, O., Lehnen, C., Fricke, M., Talucci, I., Klafki, H., Morgado, B., Lehmann, S., Münch, C., Liepold, T., Wiltfang, J., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12991 · Cited by 14
Self-citation
Efficacy of leukemia inhibitory factor as a therapeutic for permanent large vessel stroke differs among aged male and female rats
Davis, S. M., Collier, L. A., Goodwin, S., Lukins, D. E., Powell, D. K., & Pennypacker, K. R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.11.017 · Cited by 11
A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention
Um, Y. H., Choi, W. H., Jung, W. S., Park, Y. H., Lee, C. U., & Lim, H. K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.4.521 · Cited by 12

Authors: Wirths, O., Multhaup, G., Czech, C., Feldmann, N., Blanchard, V., Tremp, G., Beyreuther, K., Pradier, L., & Bayer, T. A.
Affiliations: University of Bonn (DE)
Heidelberg University (DE)
Sanofi (France) (FR)
Corresponding author: Bayer, Thomas A.
ORCID: Wirths, Oliver
Multhaup, Gerd
Czech, Christian
Pradier, Laurent
Bayer, Thomas A.
Venue: Brain Pathology
Publisher: Wiley
Published: 2002-07
Volume: 12
Issue: 3
Pages: 275-286
ISSN: 1015-6305 (ISSN-L)
1750-3639
DOI: 10.1111/j.1750-3639.2002.tb00442.x
PMC: PMC8095864
OpenAlex: W1971608812
Cited by: 125
References: 64
Citations by year: 2025: 4 · 2024: 1 · 2023: 4 · 2022: 3 · 2021: 1 · 2020: 6 · 2019: 1 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 6 · 2014: 5 · 2013: 6 · 2012: 9
FWCI: 5.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1374 d)
Locations: Brain Pathology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer Forschung Initiative
Fritz Thyssen Stiftung
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: amyloid-beta, amyloid precursor protein, presenilin 1, Alzheimer's disease, amyloid plaques, Aβ40, amyloid-beta 42, axonal transport, striatum, surface plasmon resonance
MeSH terms: Alzheimer Disease, Animals, Antibodies, Brain, Immunohistochemistry, Membrane Proteins, Mice, Transgenic, Mutation, Neurons, Time Factors, Blotting, Western, Polymerase Chain Reaction, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Surface Plasmon Resonance, Protein Transport, Mice, Presenilin-1, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Intraneuronal APP/Aβ Trafficking and Plaque Formation in β‐Amyloid Precursor Protein and Presenilin‐1 Transgenic Mice

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks